| CAS NO: | 85202-17-1 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| Cas No. | 85202-17-1 |
| 别名 | 2,8-二甲基-2,3,4,4A,5,9B-六氢-1H-吡啶并[4,3-B]吲哚二盐酸盐 |
| Canonical SMILES | CC1=CC=C2N[C@@](CCN(C3)C)([H])[C@@]3([H])C2=C1 |
| 分子式 | C13H18N2 |
| 分子量 | 202.3 |
| 溶解度 | DMSO: >100mM |
| 储存条件 | -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Stobadine is a pyridoindole antioxidant.1It scavenges hydroxyl, peroxyl, and alkoxyl radicals and quenches singlet oxygen in cell-free assays.Ex vivo, stobadine (2 mg/kg) reduces lipid peroxidation induced by hypoxia and reoxygenation in rat forebrain.2It improves survival in a rat model of carotid artery ligation-induced cerebral ischemia. Stobadine (1 mg/kg, i.v.) increases myocardial blood flow and decreases infarct area in a dog model of myocardial infarction induced by acute occlusion of the left coronary artery.1Dietary administration of stobadine (0.05% w/w) delays the development of cataracts and reduces eye lens protein oxidation and plasma levels of malondialdehyde (MDA) in a rat model of diabetes induced by streptozotocin .3 1.HorÁkovÁ, L., and štolc, S.Antioxidant and pharmacodynamic effects of pyridoindole stobadineGen. Pharmacol.30(5)627-638(1998) 2.štolc, S., VlkolinskÝ, R., and PavlÁsek, J.Neuroprotection by the pyridoindole stobadine: A minireviewBrain Res. Bull.42(5)335-340(1997) 3.Kyselova, Z., Gajdosik, A., Gajdosikova, A., et al.Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: Comparison with vitamin E and BHTMol. Vis.1156-65(2005) |
m.cnreagent.com